BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 10200622)

  • 1. [The antibacterial therapy of community-acquired pneumonia].
    Khveshchuk PF; Rakov AL; Sinopal'nikov AI; Rudakova AV
    Voen Med Zh; 1999 Jan; 320(1):25-36. PubMed ID: 10200622
    [No Abstract]   [Full Text] [Related]  

  • 2. [The place of the new quinolones in the guidelines on the treatment of community-acquired pneumonia].
    Dorca J
    Arch Bronconeumol; 1999 May; 35 Suppl 3():77-80. PubMed ID: 10410230
    [No Abstract]   [Full Text] [Related]  

  • 3. [New quinolones for the treatment of community-acquired pneumonia--contra].
    Egger M
    Dtsch Med Wochenschr; 2003 May; 128(19):1071. PubMed ID: 12736860
    [No Abstract]   [Full Text] [Related]  

  • 4. [New quinolones for the treatment of community-acquired pneumonia--pro].
    Zimmerli S
    Dtsch Med Wochenschr; 2003 May; 128(19):1070. PubMed ID: 12736859
    [No Abstract]   [Full Text] [Related]  

  • 5. [Empiric therapy of community-acquired pneumonia: a transatlantic controversy].
    Garin N; Nendaz M
    Rev Med Suisse; 2006 Jan; 2(50):289-90, 292-4. PubMed ID: 16503046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Community-acquired pneumonia.
    Torres A
    Semin Respir Crit Care Med; 2009 Apr; 30(2):125-6. PubMed ID: 19296411
    [No Abstract]   [Full Text] [Related]  

  • 7. [The role of quinolones in the treatment of community acquired pneumonia].
    Garau J
    Med Clin (Barc); 1998 Feb; 110 Suppl 1():31-5. PubMed ID: 9717158
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical experience of levofloxacin in community acquired pneumonia].
    Arancibia F; Maldonado A; Torres A
    Enferm Infecc Microbiol Clin; 1999; 17 Suppl 1():14-8. PubMed ID: 10563105
    [No Abstract]   [Full Text] [Related]  

  • 9. Drugs of choice for community-acquired bacterial pneumonia.
    Med Lett Drugs Ther; 2007 Jul; 49(1266):62-4. PubMed ID: 17652999
    [No Abstract]   [Full Text] [Related]  

  • 10. Community-acquired respiratory infections: spectrum of organisms and treatment.
    McKellar PP
    J Med Liban; 2000; 48(4):264-9. PubMed ID: 11214199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Community-acquired pneumonia: is it time to shorten the antibiotic treatment?
    Esposito S; Fiore M
    Expert Rev Anti Infect Ther; 2007 Dec; 5(6):933-8. PubMed ID: 18039078
    [No Abstract]   [Full Text] [Related]  

  • 12. [Preventive measures for drug resistant bacteria by guidelines].
    Tomono K
    Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():531-3. PubMed ID: 17455675
    [No Abstract]   [Full Text] [Related]  

  • 13. [Management of adult patients with community-acquired pneumonia. Evidence-based guidelines from the Swedish Infectious Diseases Association].
    StrĂ¥lin K; Goscinski G; Hedlund J; Lidman C; Spindler C; Ortqvist A; Holmberg H
    Lakartidningen; 2008 Sep 17-23; 105(38):2582-7. PubMed ID: 18846863
    [No Abstract]   [Full Text] [Related]  

  • 14. BTS guidelines for the management of community acquired pneumonia in adults: update 2009.
    Lim WS; Baudouin SV; George RC; Hill AT; Jamieson C; Le Jeune I; Macfarlane JT; Read RC; Roberts HJ; Levy ML; Wani M; Woodhead MA;
    Thorax; 2009 Oct; 64 Suppl 3():iii1-55. PubMed ID: 19783532
    [No Abstract]   [Full Text] [Related]  

  • 15. [Community acquired pneumonia; no reason to revise current Dutch antibiotic guidelines].
    Oosterheert JJ; Bonten MJ; Schneider MM; Hoepelman IM
    Ned Tijdschr Geneeskd; 2003 Mar; 147(9):381-6. PubMed ID: 12661455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical effects and bronchoalveolar transfer of levofloxacin in patients with community-acquired pneumonia.
    Lin Y; Su W; Xu Z; Bai Y
    Chin Med J (Engl); 2001 Feb; 114(2):212-3. PubMed ID: 11780213
    [No Abstract]   [Full Text] [Related]  

  • 17. One drug or two? Step-down therapy after i.v. antibiotics for community-acquired pneumonia.
    Harrington Z; Barnes DJ
    Intern Med J; 2007 Nov; 37(11):767-71. PubMed ID: 17908087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of atypical pathogens of community-acquired pneumonia.
    Plouffe JF
    Clin Infect Dis; 2000 Aug; 31 Suppl 2():S35-9. PubMed ID: 10984326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Newer fluoroquinolones and the management of respiratory tract infections.
    Karchmer AW
    Clin Infect Dis; 2000 Aug; 31 Suppl 2():S15. PubMed ID: 10984322
    [No Abstract]   [Full Text] [Related]  

  • 20. [The Japanese Respiratory Society guidelines for management of community-acquired pneumonia in adults].
    Matsushima T;
    Nihon Rinsho; 2003 Feb; 61 Suppl 2():677-81. PubMed ID: 12722300
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.